Yi-Ning Dai

507 total citations
11 papers, 395 citations indexed

About

Yi-Ning Dai is a scholar working on Epidemiology, Surgery and Molecular Biology. According to data from OpenAlex, Yi-Ning Dai has authored 11 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 3 papers in Surgery and 3 papers in Molecular Biology. Recurrent topics in Yi-Ning Dai's work include Liver Disease Diagnosis and Treatment (7 papers), Liver Disease and Transplantation (2 papers) and Endoplasmic Reticulum Stress and Disease (2 papers). Yi-Ning Dai is often cited by papers focused on Liver Disease Diagnosis and Treatment (7 papers), Liver Disease and Transplantation (2 papers) and Endoplasmic Reticulum Stress and Disease (2 papers). Yi-Ning Dai collaborates with scholars based in China and United States. Yi-Ning Dai's co-authors include Chaohui Yu, Jinzhou Zhu, Youming Li, Yuming Wang, Qinyi Zhou, Di Meng, Hua-Tuo Zhu, Xingyong Wan, Dejian Zhao and Youming Li and has published in prestigious journals such as World Journal of Gastroenterology, Metabolism and Digestive Diseases and Sciences.

In The Last Decade

Yi-Ning Dai

11 papers receiving 395 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi-Ning Dai China 9 197 105 95 74 71 11 395
Yanlan Fang China 6 271 1.4× 159 1.5× 96 1.0× 59 0.8× 50 0.7× 23 390
Xiaomin Pan United States 10 265 1.3× 105 1.0× 164 1.7× 88 1.2× 97 1.4× 16 574
Jinghua Wang China 11 204 1.0× 116 1.1× 63 0.7× 68 0.9× 67 0.9× 24 391
Jilin Zheng China 12 145 0.7× 74 0.7× 158 1.7× 81 1.1× 38 0.5× 26 462
Anne-Laure Sberna France 7 257 1.3× 192 1.8× 107 1.1× 116 1.6× 100 1.4× 8 484
Akemi Tsutsui Japan 12 239 1.2× 58 0.6× 125 1.3× 121 1.6× 213 3.0× 27 574
Tomohiko Ohashi Japan 14 314 1.6× 153 1.5× 94 1.0× 159 2.1× 152 2.1× 38 612
Christina‐Maria Flessa Greece 7 202 1.0× 72 0.7× 84 0.9× 36 0.5× 50 0.7× 11 319
H Wobser Germany 11 345 1.8× 119 1.1× 131 1.4× 142 1.9× 170 2.4× 22 550
Jesús Medina Spain 5 322 1.6× 114 1.1× 91 1.0× 73 1.0× 246 3.5× 6 488

Countries citing papers authored by Yi-Ning Dai

Since Specialization
Citations

This map shows the geographic impact of Yi-Ning Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi-Ning Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi-Ning Dai more than expected).

Fields of papers citing papers by Yi-Ning Dai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi-Ning Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi-Ning Dai. The network helps show where Yi-Ning Dai may publish in the future.

Co-authorship network of co-authors of Yi-Ning Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Yi-Ning Dai. A scholar is included among the top collaborators of Yi-Ning Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi-Ning Dai. Yi-Ning Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Meng, Di, et al.. (2025). Neuregulin1 ameliorates metabolic dysfunction-associated fatty liver disease via the ERK/SIRT1 signaling pathways. BMC Gastroenterology. 25(1). 47–47. 1 indexed citations
2.
Dai, Yi-Ning, Chengfu Xu, Hongying Pan, Meijuan Chen, & Chaohui Yu. (2023). Fatty liver is associated with significant liver inflammation and increases the burden of advanced fibrosis in chronic HBV infection. BMC Infectious Diseases. 23(1). 637–637. 5 indexed citations
3.
Meng, Di, Hongying Pan, Youwei Chen, Jiexia Ding, & Yi-Ning Dai. (2021). Roles and mechanisms of NRG1 in modulating the pathogenesis of NAFLD through ErbB3 signaling in hepatocytes (NRG1 modulates NAFLD through ErbB3 signaling). Obesity Research & Clinical Practice. 15(2). 145–151. 12 indexed citations
5.
Dai, Yi-Ning. (2015). IsHelicobacter pyloriinfection associated with glycemic control in diabetics?. World Journal of Gastroenterology. 21(17). 5407–5407. 35 indexed citations
6.
Zhu, Jinzhou, Hua-Tuo Zhu, Yi-Ning Dai, et al.. (2015). Serum periostin is a potential biomarker for non-alcoholic fatty liver disease: a case–control study. Endocrine. 51(1). 91–100. 32 indexed citations
7.
Zhu, Jinzhou, Yi-Ning Dai, Yuming Wang, et al.. (2015). Prevalence of Nonalcoholic Fatty Liver Disease and Economy. Digestive Diseases and Sciences. 60(11). 3194–3202. 95 indexed citations
8.
Dai, Yi-Ning, et al.. (2015). Angiotensin-converting enzyme inhibitors/angiotensin receptor blockers therapy and colorectal cancer: a systematic review and meta-analysis. Cancer Causes & Control. 26(9). 1245–1255. 37 indexed citations
9.
Dai, Yi-Ning, Jinzhou Zhu, Di Meng, Chaohui Yu, & Youming Li. (2015). Association of homocysteine level with biopsy-proven non-alcoholic fatty liver disease: a meta-analysis. Journal of Clinical Biochemistry and Nutrition. 58(1). 76–83. 51 indexed citations
10.
Dai, Yi-Ning, Jinzhou Zhu, Dejian Zhao, et al.. (2015). A case–control study: Association between serum neuregulin 4 level and non-alcoholic fatty liver disease. Metabolism. 64(12). 1667–1673. 73 indexed citations
11.
Dong, Yachen, et al.. (2013). Biodegradation of chestnut shell and lignin-modifying enzymes production by the white-rot fungi Dichomitus squalens, Phlebia radiata. Bioprocess and Biosystems Engineering. 37(5). 755–764. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026